# Pramipexole for Binge Eating Disorder

> **NCT01106053** · PHASE3 · WITHDRAWN · sponsor: **Neuropsychiatric Research Institute, Fargo, North Dakota**

## Conditions studied

- Binge Eating Disorder

## Interventions

- **DRUG:** Pramipexole

## Key facts

- **NCT ID:** NCT01106053
- **Lead sponsor:** Neuropsychiatric Research Institute, Fargo, North Dakota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-04
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were recruited and study has been closed.
- **Last updated:** 2013-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106053, "Pramipexole for Binge Eating Disorder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01106053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*